Neisseria meningitidis Serogroup W, Burkina Faso, 2012
In: Emerging Infectious Diseases, Jg. 20 (2014), Heft 3, S. 402-407
Online
academicJournal
Zugriff:
In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases in Neisseria meningitidis serogroup W, raising questions about whether these cases were a natural increase in disease or resulted from serogroup replacement after PsA-TT introduction. We analyzed national surveillance data to describe the epidemiology of serogroup W and genotyped 61 serogroup W isolates. In 2012, a total of 5,807 meningitis cases were reported through enhanced surveillance, of which 2,353 (41%) were laboratory confirmed. The predominant organism identified was N. meningitidis serogroup W (62%), and all serogroup W isolates characterized belonged to clonal complex 11. Although additional years of data are needed before we can understand the epidemiology of serogroup W after PsA–TT introduction, these data suggest that serogroup W will remain a major cause of sporadic disease and has epidemic potential, underscoring the need to maintain high-quality case-based meningitis surveillance after PsA–TT introduction. Download MP3 Length: 1:40
Titel: |
Neisseria meningitidis Serogroup W, Burkina Faso, 2012
|
---|---|
Autor/in / Beteiligte Person: | MacNeil, Jessica R. ; Medah, Isaïe ; Koussoubé, Daouda ; Novak, Ryan T. ; Cohn, Amanda C. ; Fabien V.K. Diomandé ; Yelbeogo, Denis ; Jean Ludovic Kambou ; Tarbangdo, Tiga F. ; Ouédraogo-Traoré, Rasmata ; Sangaré, Lassana ; Hatcher, Cynthia ; Vuong, Jeni ; Mayer, Leonard W. ; Djingarey, Mamoudou H. ; Clark, Thomas A. ; Messonnier, Nancy E. |
Link: | |
Zeitschrift: | Emerging Infectious Diseases, Jg. 20 (2014), Heft 3, S. 402-407 |
Veröffentlichung: | Centers for Disease Control and Prevention, 2014 |
Medientyp: | academicJournal |
ISSN: | 1080-6040 (print) ; 1080-6059 (print) |
DOI: | 10.3201/eid2003.131407 |
Schlagwort: |
|
Sonstiges: |
|